On the Importance of Diversification During Bear Markets

Diversification is one of the simplest and easiest strategies that retail investors can follow to protect their portfolios from high volatility. Holding a wide variety assets across regions and countries and sectors and avoiding timing the market would go long in generating high returns. Trying to predict which sector will be winner during the next downturn is especially hard to predict if not impossible. In addition, a sector that was the winner in the last bear market may turn to out a loser in the next one and vice versa.

The following graphic shows the performance of select sectors during the dot com collapse and the global financial crisis:

Click to enlarge

Source: Why it’s so hard to predict the next bear market, Chris Tidmore, Vanguard

From the above article:

Many active fund managers try to look into the future. They choose stocks for their funds by trying to predict which market segments will perform well.

The differences in the last 2 bear markets illustrate how hard it can be to identify which sectors and segments of the market are susceptible to a future downturn.

Figure 1 shows that when the tech bubble burst in the early 2000’s, IT, telecom, and utilities were the worst-performing sectors. During the global financial crisis, REITs, financials, and industrials performed poorly. On the other hand, REITs thrived during the tech bubble, and utilities performed the best during the financial crisis.

The key takeaway is that a sector that performs poorly in one bear market may turn out be the best performer in the following one and vice versa.

Per Capita Income Comparison of BRICS Countries

The per capita income among BRICS countries vary widely. Russia has the highest per capita income at about $11,000. India has the lowest at $2,000 as shown in the chart below:

Click to enlarge

 

Source: India’s Strong Economy Continues to Lead Global Growth, IMF

The IMF article notes that India’s per capita income is well below than other large emerging peers and India needs to accelerate reforms to keep the maintain job growth.

Which Firms Dominate The Global Diabetes Market?

Diabetes is becoming prevalent disease in globally especially in the developing world. Though there are plenty of players in the market for treating Diabetes, four major global drug companies dominate the market.

From an article on the diabetes market in China:

At present, the competition in the diabetes market is fierce. Traditional Insulin is still the most popular drug category and accounts for about half of the market. The rest is shared among GLP-1 receptor agonists (17%), DPP-4 inhibitors (21%), and SGLT2 inhibitors (6%), which are regarded as the rising stars. The current global diabetes market is mainly divided by four giant monopolies, Novo Nordisk, Sanofi, Eli Lilly, and Merck. Combined, they account for about 72% of the market.

 

Source: The Diabetes Market in China, Pharma Exec

Investors looking to profit from the growing diabetes epidemic can consider adding some the drug makers in this field. The ADR tickers of the four major players are shown below:

1. Novartis AG (NVS)

2. Eli Lilly (LLY)

3. Sanofi (SNY)

4. Merck (MRK)

Disclosure: No Positions